Literature DB >> 2273252

An ELISA employing a Haemophilus influenzae type b oligosaccharide-human serum albumin conjugate correlates with the radioantigen binding assay.

D C Phipps1, J West, R Eby, M Koster, D V Madore, S A Quataert.   

Abstract

An ELISA measuring total Ig antibodies to the capsular polysaccharide of Haemophilus influenzae type b (HbPs) in human sera using an antigen composed of Haemophilus b oligosaccharides conjugated to human serum albumin (HbO-HA) was shown to have an excellent correlation to the radioantigen binding assay (RABA). When 214 sera with different anti-HbPs levels were assayed for total Ig by HbO-HA ELISA and by RABA the correlation coefficient was 0.917 and the paired t test p value was 0.575. Use of competitive ELISA employing soluble HbPs, HbO-HA and human albumin as competitors, showed that the HbO-HA ELISA was specific for antibodies to HbPs. The HbO-HA ELISA yielded reproducible results both within and between laboratories. The HbO-HA ELISA can also be used to determine the isotype of anti-HbPs antibodies by using isotype specific enzyme conjugates. The sum of the IgG, IgA and IgM HbO-HA ELISA results had excellent correlation to the RABA results (correlation coefficient = 0.976). Thus, the HbO-HA ELISA can be substituted for the classical RABA and also be utilized for quantitating the isotype of the anti-HbPs antibodies.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2273252     DOI: 10.1016/0022-1759(90)90264-v

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  34 in total

1.  Interlaboratory reproducibility of an enzyme-linked immunosorbent assay for quantitation of antibodies for Haemophilus influenzae type b polysaccharide.

Authors:  D V Madore; S A Quataert
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

2.  Immunologic memory in Haemophilus influenzae type b conjugate vaccine failure.

Authors:  J McVernon; P D R Johnson; A J Pollard; M P E Slack; E R Moxon
Journal:  Arch Dis Child       Date:  2003-05       Impact factor: 3.791

3.  Effect of a fourth Haemophilus influenzae type b immunisation in preterm infants who received dexamethasone for chronic lung disease.

Authors:  P Clarke; P J Powell; D Goldblatt; M J Robinson
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-01       Impact factor: 5.747

4.  Simultaneous detection of Haemophilus influenzae type b polysaccharide-specific antibodies and Neisseria meningitidis serogroup A, C, Y, and W-135 polysaccharide-specific antibodies in a fluorescent-bead-based multiplex immunoassay.

Authors:  Richarda M de Voer; Rutger M Schepp; Florens G A Versteegh; Fiona R M van der Klis; Guy A M Berbers
Journal:  Clin Vaccine Immunol       Date:  2009-01-07

5.  A competitive enzyme-linked immunosorbent assay for measuring the levels of serum antibody to Haemophilus influenzae type b.

Authors:  M Mariani; E Luzzi; D Proietti; S Mancianti; D Casini; P Costantino; P van Gageldonk; G Berbers
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

6.  Differing antibody responses to Haemophilus influenzae type b after meningitis or epiglottitis.

Authors:  P D Johnson; M Hanlon; D Isaacs; G L Gilbert
Journal:  Epidemiol Infect       Date:  1996-02       Impact factor: 2.451

7.  Immunogenicity of Haemophilus influenzae type b protein conjugate vaccines in very low birth weight infants.

Authors:  Carl T D'Angio; Theresa E Murray; Lei Li; Roy J Heyne; T Michael O'Shea; Robert L Schelonka; Seetha Shankaran; Shahnaz Duara; Ronald N Goldberg; Barbara J Stoll; David K Stevenson; Betty R Vohr; Dale L Phelps; Waldemar A Carlo; Michael E Pichichero; Abhik Das; Rosemary D Higgins
Journal:  Pediatr Infect Dis J       Date:  2013-12       Impact factor: 2.129

8.  Comparison of nonhuman primate antibodies against Haemophilus influenzae type b polysaccharide with human antibodies in oligoclonality and in vivo protective potency.

Authors:  K H Kim; M K Park; C C Peeters; J T Poolman; M H Shearer; R C Kennedy; M H Nahm
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

9.  Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and haemophilus influenzae type b conjugate vaccine in healthy infants in the United Kingdom primed with a monovalent meningococcal serogroup C vaccine.

Authors:  Ray Borrow; Nick Andrews; Helen Findlow; Pauline Waight; Joanna Southern; Annette Crowley-Luke; Lorraine Stapley; Anna England; Jamie Findlow; Elizabeth Miller
Journal:  Clin Vaccine Immunol       Date:  2009-11-11

10.  The impact of an early truncating founder ATM mutation on immunoglobulins, specific antibodies and lymphocyte populations in ataxia-telangiectasia patients and their parents.

Authors:  A Stray-Pedersen; T Jónsson; A Heiberg; C R Lindman; E Widing; I S Aaberge; A L Borresen-Dale; T G Abrahamsen
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.